Tag Archives: hormone receptor-positive breast cancer

Bio-Techne Corporation today announced that Asuragen, a Bio-Techne brand, launched a highly sensitive ESR1 mutation monitoring assay. ESR1 gene mutations are known to be linked to...

Read More »